The objective of the present study was to validate a dosing
regimen involving loading and maintenance doses of clopidogrel
that was designed to induce the inhibition of platelet function, as
measured by whole blood impedance aggregometry in healthy adult
Warmblood horses. We hypothesised that this dosing regimen would
inhibit platelet aggregation within hours and maintain this inhibition
over at least the next four days.